InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.6%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Loewald Thomas W, Director. Officer active across 2 companies, notably HARVARD BIOSCIENCE INC. In total, 9 disclosures have been logged. Activity tracked since 25 May 2021. The latest transaction was disclosed on 21 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
45,872 shares0Common StockSEC:0000921895-24-001306:0
25,554 shares0Common StockSEC:0000921895-23-001328:0
38,259 shares0Common StockSEC:0000921895-22-001803:0
2,525 shares0Common StockSEC:0000921895-22-000033
2,525 shares0Common StockSEC:0000921895-22-000033:0
1,401 shares0Common StockSEC:0000921895-21-002901:0
1,401 shares0Common StockSEC:0000921895-21-002901
14,400 shares0Common StockSEC:0000921895-21-001512
14,400 shares0Common StockSEC:0000921895-21-001512:0
9 of 9 declarations
About Loewald Thomas W
Thomas W. Loewald is a Board Member at Harvard Bioscience Inc. He plays a key role in the governance of the company, contributing to strategy and decision-making. His experience in the biopharmaceutical sector is valuable in guiding Harvard Bioscience in its development and innovation initiatives.
